A balanced review of the status T cell-based therapy against cancer
<p>Abstract</p> <p>A recent commentary stirred intense controversy over the status of anti-cancer immunotherapy. The commentary suggested moving beyond current anti-cancer vaccines since active-specific immunization failed to match expectations toward a more aggressive approach inv...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2005-04-01
|
Series: | Journal of Translational Medicine |
Online Access: | http://www.translational-medicine.com/content/3/1/16 |
id |
doaj-00948f2efc1948e5a5849f4f3a7cd2d0 |
---|---|
record_format |
Article |
spelling |
doaj-00948f2efc1948e5a5849f4f3a7cd2d02020-11-24T21:40:18ZengBMCJournal of Translational Medicine1479-58762005-04-01311610.1186/1479-5876-3-16A balanced review of the status T cell-based therapy against cancerMarincola Francesco M<p>Abstract</p> <p>A recent commentary stirred intense controversy over the status of anti-cancer immunotherapy. The commentary suggested moving beyond current anti-cancer vaccines since active-specific immunization failed to match expectations toward a more aggressive approach involving the adoptive transfer of in vitro expanded tumor antigen-specific T cells. Although the same authors clarified their position in response to others' rebuttal more discussion needs to be devoted to the current status of T cell-based anti-cancer therapy. The accompanying publications review the status of adoptive transfer of cancer vaccines on one hand and active-specific immunization on the other. Hopefully, reading these articles will offer a balanced view of the current status of antigen-specific ant-cancer therapies and suggest future strategies to foster unified efforts to complement either approach with the other according to specific biological principles.</p> http://www.translational-medicine.com/content/3/1/16 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Marincola Francesco M |
spellingShingle |
Marincola Francesco M A balanced review of the status T cell-based therapy against cancer Journal of Translational Medicine |
author_facet |
Marincola Francesco M |
author_sort |
Marincola Francesco M |
title |
A balanced review of the status T cell-based therapy against cancer |
title_short |
A balanced review of the status T cell-based therapy against cancer |
title_full |
A balanced review of the status T cell-based therapy against cancer |
title_fullStr |
A balanced review of the status T cell-based therapy against cancer |
title_full_unstemmed |
A balanced review of the status T cell-based therapy against cancer |
title_sort |
balanced review of the status t cell-based therapy against cancer |
publisher |
BMC |
series |
Journal of Translational Medicine |
issn |
1479-5876 |
publishDate |
2005-04-01 |
description |
<p>Abstract</p> <p>A recent commentary stirred intense controversy over the status of anti-cancer immunotherapy. The commentary suggested moving beyond current anti-cancer vaccines since active-specific immunization failed to match expectations toward a more aggressive approach involving the adoptive transfer of in vitro expanded tumor antigen-specific T cells. Although the same authors clarified their position in response to others' rebuttal more discussion needs to be devoted to the current status of T cell-based anti-cancer therapy. The accompanying publications review the status of adoptive transfer of cancer vaccines on one hand and active-specific immunization on the other. Hopefully, reading these articles will offer a balanced view of the current status of antigen-specific ant-cancer therapies and suggest future strategies to foster unified efforts to complement either approach with the other according to specific biological principles.</p> |
url |
http://www.translational-medicine.com/content/3/1/16 |
work_keys_str_mv |
AT marincolafrancescom abalancedreviewofthestatustcellbasedtherapyagainstcancer AT marincolafrancescom balancedreviewofthestatustcellbasedtherapyagainstcancer |
_version_ |
1725926813377495040 |